FLAIA Marketplace

Medical Cannabis
Share
https://flaia-cms-assets.s3.amazonaws.com/Pharma_Rolly_Final_Logo_03_cfd6895a8a.png
  • Expires: 2024-12-31
  • Min Investment: $500,000
  • Target Return: 20% - 100%+
  • Lockup: Permanent Capital

Strategy

PharmaRolly Holdings B.V., a trailblazer in the THC-dominant medical cannabis industry, and take advantage of the booming European cannabis market. PharmaRolly, headquartered in the Netherlands with a wholly-owned subsidiary in North Macedonia, is committed to producing high-quality, organic medical cannabis products. With a robust infrastructure, experienced management team, and strategic market positioning, PharmaRolly is poised for significant growth and exceptional investment returns.

Team

Stephen Malloy
Founder & CEO @ PharmaRolly

About

PharmaRolly

PharmaRolly, a Dutch company operating at the highest international standards, is the only operator to elevate fully organic living soil-grown craft cannabis to a commercialized, standardized, and purified end product at the most competitive prices in Europe – putting patient access to organic medicine first.